Profile

Rna Diagnostics is a clinical stage molecular diagnostics company. VERIDAPT DX™ enables precision oncology through prediction of on-treatment tumor response. VERIDAPT DX™ is validated in > 1000 patients in prospective and retrospective clinical studies. No other biomarkers are positioned to accurately predict patient response within 5 weeks of initiation of neoadjuvant cancer treatment. Oncologists use VERIDAPT DX™ to optimize treatments in real time. VERIDAPT DX™ enables Improved outcomes for patients and cost savings for payers.

Rna Diagnostics Inc. logo

Website

rnadiagnostics.com

Contact


Event details

Date: October 15 - 17, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

20 in total